Nadolol (Corgard) in severe and resistant hypertension

A total of 12 severely hypertensive patients were treated with a once daily dose ofNadolol. There was a drop in diastolic pressure to a mean of 105 mm Hg standing within two weeks and this was well maintained up to 12 months of therapy, the lowest diastolic pressure being 94 mm Hg standing at six months of therapy. Nadolol produced no significant side effects and bradycardia was not a problem during treatment. Of the eleven patients who were resistant to previous therapy because of various reasons all except two responded excellently. One of the non responders has real resistance to therapy and the other is non compliant. Nadolol is found to be an effective once daily treatment for severe and resistant hypertension.